NovaSom
NovaSom is a Glen Burnie, Maryland-based private company developing home obstructive sleep apnea testing devices with cardio-respiratory monitoring capability. Founded in 1992, the firm is in a pre-launch phase, currently operating only a "Launching Soon" website and email signup flow.
- Company typePrivate
- Founded1992
- HeadquartersGlen Burnie, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What NovaSom does
NovaSom is a private, for-profit company headquartered in Glen Burnie, Maryland, positioned in the home obstructive sleep apnea (OSA) testing market. Per available firmographic data, the company was founded in 1992 and operates with 51-100 employees, with John Spitznagel identified as CEO. Its stated product offering is home sleep apnea testing devices with cardio-respiratory monitoring capability, a category that traditionally requires FDA clearance and is sold to clinicians, sleep specialists, durable medical equipment (DME) providers, and increasingly direct to consumers.
The company's public commercial footprint is currently limited to a "Launching Soon" landing page with an email-capture form, suggesting a pre-launch or relaunch phase as of 2025. No products, pricing models, distribution channels, certifications, patents, customer logos, partnerships, or management team beyond the CEO are disclosed in available sources. Historical capital formation totals approximately $70.5 million across five disclosed rounds between January 2011 and January 2018, with named investors including Quaker BioVentures, Safeguard Scientifics (lead on the Series 3 in June 2011), and Armentum Partners (2018). No funding activity is recorded after 2018.
The business model is not articulated in current public materials: pricing is explicitly undisclosed, no distribution channels are listed, no customer segments are defined, and the only demand-generation mechanism is website email signup. The "Launching Soon" status, combined with the long gap since the last capital event and the absence of disclosed revenue, indicates the company is preparing for a market entry rather than scaling an existing revenue base. As a result, revenue estimation, customer concentration, and competitive positioning assessment are constrained by data gaps and should be revisited when product, pricing, and launch materials are published.
NovaSom firmographics
Firmographics- Name
- NovaSom
- Legal name
- Novasom
- Website
- https://novasom.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- NovaSom is a Glen Burnie, Maryland-based private company developing home obstructive sleep apnea testing devices with cardio-respiratory monitoring capability. Founded in 1992, the firm is in a pre-launch phase, currently operating only a "Launching Soon" website and email signup flow.
- Ownership category
- akta.pro rank
NovaSom industry classification
Industry- Product category
- Sleep Apnea Diagnostic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Measuring & Controlling Devices, Nec (3829)
- akta.pro primary industry
- Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)
- akta.pro secondary industries
- Respiratory & Sleep RPM (COPD, asthma, sleep apnea) (HLALAFAB), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)
Keywords
Where NovaSom is headquartered
LocationHeadquarters
- HQ city
- Glen Burnie
- HQ country
- United States
- HQ region
- North America
Markets served
NovaSom business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Marketing channels1 record
NovaSom product offering
Product offeringCore offering
NovaSom designs and provides home-based obstructive sleep apnea testing devices with integrated cardio-respiratory monitoring capability. The product enables patients to undergo diagnostic sleep studies outside a traditional sleep laboratory while delivering respiratory and cardiac physiological data to physicians for clinical evaluation. The company is preparing a commercial relaunch, as its website currently displays a 'Launching Soon' status.
Product overview
NovaSom is a company in the home sleep apnea testing devices market. Based on the available source data, the company website shows only a 'Launching Soon' landing page with no specific products, services, or detailed offerings disclosed.
Differentiator
Problem solved
Functional benefit
Products and services
- NovaSom Home Sleep Apnea Test Device A home-based obstructive sleep apnea testing device with integrated cardio-respiratory monitoring capability, used by physicians (typically sleep medicine specialists and pulmonologists) to diagnose OSA in patients outside of a traditional sleep laboratory.
Companies that use NovaSom
Customer profileIdeal customer profiles1 record
NovaSom technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
NovaSom partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights3 records
NovaSom competitors and assessment
Company assessmentBroad incumbents
- ResMed: Global leader in sleep apnea therapy (CPAP) and HSAT (ApneaLink Air). ResMed competes via its own home sleep testing devices and through the Itamar Medical acquisition, making it a broad incumbent with overlapping diagnostic offerings.
- React Health (formerly 3B Medical / Invacare Supply Group): Respiratory and sleep therapy company distributing PAP and related home diagnostic/monitoring products in the U.S. Serves overlapping DME and clinician channels that NovaSom would target.
- Koninklijke Philips: Broad incumbent offering the Alice NightOne home sleep testing device alongside its CPAP and hospital sleep lab portfolios. Larger and more diversified than NovaSom but overlapping in HSAT device sales channels.
Direct peers
- Itamar Medical: WatchPAT manufacturer and direct competitor in the home sleep apnea testing device category. Itamar offers finger-based PAT (peripheral arterial tone) cardio-respiratory monitoring, overlapping strongly with NovaSom's described capability.
- Nox Medical: Manufactures the Nox T3 and related home/portable sleep monitoring systems used in HSAT and ambulatory polysomnography. Direct overlap in device class, target clinicians, and cardio-respiratory signal capture.
- CleveMed: Maker of the SleepView at-home sleep apnea test, a directly competing HSAT device sold to clinicians and through DME channels. Comparable product category, reimbursement pathway, and target end-user.
- Compumedics: Sleep diagnostics company offering the Somte PSG and Somfit home sleep testing device. Competes in the same HSAT category with overlapping clinical end-users (sleep specialists, hospitals).
- SOMNOmedics: German manufacturer of SOMNOwatch and related ambulatory/home sleep monitoring devices. Comparable in providing cardio-respiratory signal capture in compact, ambulatory form factors aimed at HSAT.
Emerging players
- BMC Medical: China-based sleep and respiratory device maker expanding internationally with PAP, masks, and home sleep testing products. An emerging competitor targeting the same OSA diagnostic and therapy value chain.
Regional players
- Cidelec: European sleep diagnostics specialist offering home and ambulatory PSG/HSAT systems. Comparable product class but primarily Europe-focused, so a regional rather than direct U.S. competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
NovaSom social profiles
Digital presenceNovaSom financial estimates
Financial estimateRevenue estimate
Valuation estimate
NovaSom leadership team
Management profileNumber of profiles
Profiles1 record
NovaSom funding detail
Funding detailFunding overview
Funding rounds5 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NovaSom M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NovaSom
What does NovaSom do?
NovaSom designs and provides home-based obstructive sleep apnea testing devices with integrated cardio-respiratory monitoring capability. The product enables patients to undergo diagnostic sleep studies outside a traditional sleep laboratory while delivering respiratory and cardiac physiological data to physicians for clinical evaluation. The company is preparing a commercial relaunch, as its website currently displays a 'Launching Soon' status.
When was NovaSom founded?
NovaSom was founded in 1992. It employs 51 to 100 people.
Where is NovaSom based?
NovaSom is headquartered in Glen Burnie, United States, in the North America region.
Who are NovaSom's main competitors?
Broad incumbents on record are ResMed, React Health (formerly 3B Medical / Invacare Supply Group) and Koninklijke Philips. Direct peers are Itamar Medical, Nox Medical, CleveMed, Compumedics and SOMNOmedics. BMC Medical is listed as an emerging player. Cidelec is listed as a regional player.
Does NovaSom have an API?
No public API is recorded for NovaSom.
What industry is NovaSom in?
NovaSom's product category is Sleep Apnea Diagnostic Devices. Its primary akta.pro industry code is HLAHAGAB, Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy), with a secondary code of HLALAFAB, Respiratory & Sleep RPM (COPD, asthma, sleep apnea). Its NAICS code is 334510 and its SIC code is 3841.